Get the word out. Share this event with your colleagues. Click to post.

Diversity in Clinical Trials

Diversity in Clinical Trials
Tuesday, November 29, 2022 | 6:30 p.m. - 7:15 p.m.
Online registration is now closed. Please call Customer relations at 212 382 6663 to register or for assistance.
Program Fee:
Free for Members and Non-Lawyers | $15 Non-Members
Non-Lawyers please call Customer Relations at 212-382-6663 to register. 

Please Note: A final confirmation containing the Zoom link and Access Code to join the event will be sent to ALL registrants 2 hours prior to the start of the event.  

Historically there has been a lack of diversity with respect to participation in clinical trials of new drugs. This underrepresentation can mask health and safety effects of a drug on diverse populations. The panel of speakers will address the historical lack of diversity in clinical trials as well as recommendations for promoting diversity in clinical trials, including a draft Guidance issued by the FDA in 2022.

Marta E. Delsignore, Goodwin Procter LLP

Dr. Alex Helman, Senior Program Officer, Committee on Women in Science, Engineering, and Medicine, Policy and Global Affairs Division, National Academies of Sciences, Engineering, and Medicine
Sharon H Hrynkow PhD, Founder and Managing Partner, Global Health Consulting LLC
Elizabeth Mulkey, Goodwin Procter LLP

Sponsoring Committee:
Science & the Law, Irene Byhovsky, Chair

Co-Sponsoring Committees:
Bioethical Issues, Anne Zimmerman, Chair
Diversity, Equity, and Inclusion, Brittani McDonald and David Sarnoff, Co-Chairs

Health Law, Heather A. Hatcher, Chair

Online Event

Please Sign In to Register